| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Landos Biopharma, Inc. | Chief Executive Officer, Director | Restricted Stock Unit | 0 | $0 | $0.69 | May 23, 2024 | Direct |
| First Wave BioPharma, Inc. | Director | Stock option (right to buy) | 34.5K | Jan 3, 2022 | Direct | ||
| Landos Biopharma, Inc. | Chief Executive Officer, Director | Employee Stock Option (right to buy) | 0 | May 23, 2024 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| LABP | Landos Biopharma, Inc. | May 23, 2024 | 3 | $0 | 4 | May 23, 2024 | Chief Executive Officer, Director |
| LABP | Landos Biopharma, Inc. | Feb 29, 2024 | 1 | $0 | 4 | Mar 4, 2024 | Chief Executive Officer, Director |
| LABP | Landos Biopharma, Inc. | Feb 28, 2023 | 1 | $0 | 4 | Mar 2, 2023 | Chief Executive Officer, Director |
| LABP | Landos Biopharma, Inc. | Jun 20, 2022 | 1 | $0 | 4 | Jun 22, 2022 | Chief Executive Officer, Director |
| LABP | Landos Biopharma, Inc. | Jun 20, 2022 | 0 | $0 | 3 | Jun 22, 2022 | Chief Executive Officer, Director |
| FWBI | First Wave BioPharma, Inc. | Jan 3, 2022 | 1 | $0 | 4 | Jan 3, 2022 | Director |